Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Sales | -1,962 | 1,999 | 1,557 | 1,104 | 1,049 |
| Cost of Goods | N/A | 110 | 110 | 100 | N/A |
| Gross Profit | -1,962 | 1,880 | 1,440 | 1,000 | 1,049 |
| Operating Expenses | 0 | 9,710 | 7,690 | 5,680 | 0 |
| Operating Income | -1,962 | -7,711 | -6,133 | -4,576 | 1,049 |
| Interest Expense | 0 | 160 | 560 | 0 | 0 |
| Other Income | 0 | 231 | -87 | -24 | 0 |
| Pre-tax Income | -1,962 | -7,640 | -6,780 | -4,600 | 1,049 |
| Net Income Continuous | -1,962 | -7,643 | -6,782 | -4,609 | -6,248 |
| Net Income | $-1,962 | $-7,643 | $-6,782 | $-4,609 | $-6,248 |
| EPS Basic Total Ops | N/A | -0.24 | -0.26 | -0.18 | -0.24 |
| EPS Basic Continuous Ops | N/A | -0.24 | -0.26 | -0.18 | -0.24 |
| EPS Diluted Total Ops | N/A | -0.24 | -0.26 | -0.18 | -0.24 |
| EPS Diluted Continuous Ops | N/A | -0.24 | -0.26 | -0.18 | -0.24 |
| EBITDA(a) | $-697 | $-5,771 | $-4,903 | $-3,596 | $1,049 |